Ensign Peak Advisors Inc raised its position in Hamilton Lane Incorporated (NASDAQ:HLNE - Free Report) by 78.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 29,053 shares of the company's stock after buying an additional 12,769 shares during the quarter. Ensign Peak Advisors Inc owned 0.05% of Hamilton Lane worth $4,301,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also modified their holdings of the company. Price T Rowe Associates Inc. MD lifted its position in shares of Hamilton Lane by 229.7% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 1,292,266 shares of the company's stock worth $191,321,000 after buying an additional 900,283 shares during the last quarter. Vanguard Group Inc. increased its holdings in Hamilton Lane by 28.4% in the 4th quarter. Vanguard Group Inc. now owns 3,901,933 shares of the company's stock worth $577,681,000 after purchasing an additional 863,326 shares in the last quarter. Norges Bank bought a new position in Hamilton Lane in the fourth quarter valued at about $68,909,000. Invesco Ltd. boosted its stake in shares of Hamilton Lane by 25.3% during the fourth quarter. Invesco Ltd. now owns 1,923,253 shares of the company's stock valued at $284,738,000 after purchasing an additional 388,019 shares in the last quarter. Finally, Artemis Investment Management LLP acquired a new position in shares of Hamilton Lane during the fourth quarter worth $30,350,000. 97.40% of the stock is currently owned by institutional investors and hedge funds.
Hamilton Lane Stock Down 1.2%
Shares of HLNE traded down $2.09 on Tuesday, reaching $170.43. The company's stock had a trading volume of 48,133 shares, compared to its average volume of 510,747. The stock has a market capitalization of $9.45 billion, a PE ratio of 31.45 and a beta of 1.31. The company has a current ratio of 4.19, a quick ratio of 4.19 and a debt-to-equity ratio of 0.34. Hamilton Lane Incorporated has a twelve month low of $114.85 and a twelve month high of $203.72. The firm has a fifty day moving average of $149.86 and a 200-day moving average of $159.54.
Hamilton Lane Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Friday, April 4th. Investors of record on Friday, March 14th were issued a dividend of $0.49 per share. The ex-dividend date of this dividend was Friday, March 14th. This represents a $1.96 annualized dividend and a yield of 1.15%. Hamilton Lane's dividend payout ratio (DPR) is currently 36.16%.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently weighed in on the stock. JPMorgan Chase & Co. decreased their price objective on shares of Hamilton Lane from $176.00 to $167.00 and set a "neutral" rating for the company in a research report on Tuesday, April 29th. Wells Fargo & Company lowered their target price on Hamilton Lane from $152.00 to $147.00 and set an "equal weight" rating for the company in a report on Tuesday, April 8th. Oppenheimer cut Hamilton Lane from an "outperform" rating to a "market perform" rating in a report on Thursday, May 15th. Morgan Stanley lowered their price objective on shares of Hamilton Lane from $190.00 to $157.00 and set an "equal weight" rating for the company in a research note on Monday, April 14th. Finally, Keefe, Bruyette & Woods increased their target price on shares of Hamilton Lane from $158.00 to $168.00 and gave the stock a "market perform" rating in a research note on Wednesday, February 5th. One analyst has rated the stock with a sell rating and six have assigned a hold rating to the company. Based on data from MarketBeat, the stock has an average rating of "Hold" and an average price target of $164.14.
View Our Latest Report on HLNE
About Hamilton Lane
(
Free Report)
Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.
Featured Stories

Before you consider Hamilton Lane, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hamilton Lane wasn't on the list.
While Hamilton Lane currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.